Funded Tech Companies
Amarantus BioScience Holdings
Amarantus BioScience Holdings, based in New York, has financial backing from private investors, InterWest Partners, Thomas and McNerny & Partners.
Company Overview
Company Name
Amarantus BioScience Holdings
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
45 Wall St. 920
New York, NY 10005
USA
New York, NY 10005
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Amarantus BioScience Holdings, Inc. (NASDAQ: AMBS) is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/3/2013
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerald Commissiong
Chief Scientific Officer
John Commissiong
VP - Operations
Elise Brownell
VP - Regulatory Affairs
Brian Harvey
Company Investors
- InterWest Partners (Arnold Oronsky)
- Thomas, McNerny & Partners (Pratik Shah)
Browse more funded tech companies:
Amaranth Medical | Amastan Technologies
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs